Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

The company continues to develop innovative products to solve the ... Apart from Globus Medical, several other prominent players in the spinal surgery field are driving important advancements ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products ... instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures.

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products ... used in an expansive range of spinal, orthopedic and neurosurgical procedures.

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...